Literature DB >> 31953651

The effect of hyperbaric oxygenation therapy on myocardial function.

Marina Leitman1,2, Shai Efrati3,4,5, Shmuel Fuchs6,4, Amir Hadanny3,4,5, Zvi Vered6,4.   

Abstract

Hyperbaric oxygenation therapy is successfully implemented for the treatment of several disorders. Data on the effect of hyperbaric oxygenation on echocardiographic parameters in asymptomatic patients is limited. The current study sought to evaluate the effect of hyperbaric oxygenation therapy on echocardiographic parameters in asymptomatic patients. Thirty-one consecutive patients underwent a 60-sessions course of hyperbaric oxygenation therapy in an attempt to improve cognitive impairment. In all subjects, echocardiography examination was performed before and after a course of hyperbaric oxygenation therapy. Conventional and speckle tracking imaging parameters were calculated and analyzed. The mean age was 70 ± 9.5 years, 28 [90%] were males. History of coronary artery disease was present in 12 [39%]. 94% suffered from hypertension, 42% had diabetes mellitus. Baseline wall motion abnormalities were found in eight patients, however, global ejection fraction was within normal limits. During the study, ejection fraction [EF], increased from 60.71 ± 6.02 to 62.29 ± 5.19%, p = 0.02. Left ventricular end systolic volume [LVESV], decreased from 38.08 ± 13.30 to 35.39 ± 13.32 ml, p = 0.01. Myocardial performance index [MPi] improved, from 0.29 ± 0.07 to 0.26 ± 0.08, p = 0.03. Left ventricular [LV] global longitudinal strain increased from - 19.31 ± 3.17% to - 20.16 ± 3.34%, p = 0.036 due to improvement in regional strain in the apical and antero-septal segments. Twist increased from 18.32 ± 6.61° to 23.12 ± 6.35° p = 0.01, due to improvement in the apical rotation, from 11.76 ± 4.40° to 16.10 ± 5.56°, p = 0.004. Hyperbaric oxygen therapy appears to improve left ventricular function, especially in the apical segments, and is associated with better cardiac performance. If our results are confirmed in further studies, HBOT can be used in many patients with heart failure and systolic dysfunction.

Entities:  

Keywords:  Cardiac function; Echocardiography; Hyperbaric oxygenation

Year:  2020        PMID: 31953651     DOI: 10.1007/s10554-020-01773-0

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  51 in total

1.  Haemodynamic effects of hyperbaric hyperoxia in healthy volunteers: an echocardiographic and Doppler study.

Authors:  Florence Molénat; Alain Boussuges; Aliocha Grandfond; Jean-Claude Rostain; Jean-Marie Sainty; Claude Robinet; François Galland; Jean Louis Meliet
Journal:  Clin Sci (Lond)       Date:  2004-04       Impact factor: 6.124

2.  Normal references of right ventricular strain values by two-dimensional strain echocardiography according to the age and gender.

Authors:  Jae-Hyeong Park; Jin-Oh Choi; Seung Woo Park; Goo-Yeong Cho; Jin Kyung Oh; Jae-Hwan Lee; In-Whan Seong
Journal:  Int J Cardiovasc Imaging       Date:  2017-07-27       Impact factor: 2.357

Review 3.  Hyperbaric oxygen, vasculogenic stem cells, and wound healing.

Authors:  Katina M Fosen; Stephen R Thom
Journal:  Antioxid Redox Signal       Date:  2014-05-19       Impact factor: 8.401

4.  Left ventricular torsion is equal in mice and humans.

Authors:  R E Henson; S K Song; J S Pastorek; J J Ackerman; C H Lorenz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-04       Impact factor: 4.733

5.  Enhancement of satellite cell differentiation and functional recovery in injured skeletal muscle by hyperbaric oxygen treatment.

Authors:  Masaki Horie; Mitsuhiro Enomoto; Manabu Shimoda; Atsushi Okawa; Shumpei Miyakawa; Kazuyoshi Yagishita
Journal:  J Appl Physiol (1985)       Date:  2013-12-12

6.  Pulmonary edema associated with hyperbaric oxygen therapy.

Authors:  L K Weaver; S Churchill
Journal:  Chest       Date:  2001-10       Impact factor: 9.410

7.  The Effect of Hyperbaric Oxygen Therapy on Myocardial Perfusion after the Implantation of Drug-Eluting Stents.

Authors:  Yuan Li; Yafeng Hao; Tao Wang; Lingge Wei; Wei Wang; Yi Liang; Xuan Guo
Journal:  Ann Clin Lab Sci       Date:  2018-03       Impact factor: 1.256

8.  Hyperbaric oxygen increases the contractile function of regenerating rat slow muscles.

Authors:  Paul Gregorevic; David A Williams; Gordon S Lynch
Journal:  Med Sci Sports Exerc       Date:  2002-04       Impact factor: 5.411

9.  CD34+/CD45-dim stem cell mobilization by hyperbaric oxygen - changes with oxygen dosage.

Authors:  Marvin Heyboer; Tatyana N Milovanova; Susan Wojcik; William Grant; Mary Chin; Kevin R Hardy; David S Lambert; Christopher Logue; Stephen R Thom
Journal:  Stem Cell Res       Date:  2014-02-28       Impact factor: 2.020

10.  Hyperbaric Oxygen Therapy Enhanced Circulating Levels of Endothelial Progenitor Cells and Angiogenesis Biomarkers, Blood Flow, in Ischemic Areas in Patients with Peripheral Arterial Occlusive Disease.

Authors:  Pao-Yuan Lin; Pei-Hsun Sung; Sheng-Ying Chung; Shan-Ling Hsu; Wen-Jung Chung; Jiunn-Jye Sheu; Shu-Kai Hsueh; Kuan-Hung Chen; Re-Wen Wu; Hon-Kan Yip
Journal:  J Clin Med       Date:  2018-12-14       Impact factor: 4.241

View more
  3 in total

Review 1.  The neuroprotective effects of oxygen therapy in Alzheimer's disease: a narrative review.

Authors:  Cui Yang; Qiu Yang; Yang Xiang; Xian-Rong Zeng; Jun Xiao; Wei-Dong Le
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

Review 2.  Hyperbaric oxygen therapy for healthy aging: From mechanisms to therapeutics.

Authors:  Qiaoyu Fu; Ran Duan; Yu Sun; Qingfeng Li
Journal:  Redox Biol       Date:  2022-05-27       Impact factor: 10.787

3.  Hyperbaric oxygen therapy effectively alleviates D-galactose-induced-age-related cardiac dysfunction via attenuating mitochondrial dysfunction in pre-diabetic rats.

Authors:  Cherry Bo-Htay; Thazin Shwe; Thidarat Jaiwongkam; Sasiwan Kerdphoo; Wasana Pratchayasakul; Thienchai Pattarasakulchai; Krekwit Shinlapawittayatorn; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Aging (Albany NY)       Date:  2021-04-16       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.